Cardiovascular disease (CVD) is the leading cause of death of women across all ages, and
targeting modifiable risk factors, such as those comprised in metabolic syndrome (MetS)(eg …

Mothers influence the health and disease trajectories of their children, particularly during the
critical developmental windows of fetal and neonatal life reflecting the gestational–fetal and …

Context Maternal prepregnancy body mass index (BMI) has a strong influence on
gestational metabolism, but detailed metabolic alterations are unknown. Objective First, to …

Objective To assess the associations of maternal prepregnancy body mass index (BMI) and
rates of early‐pregnancy, mid‐pregnancy and total gestational weight gain with adolescent …

Background Maternal obesity is increasing worldwide but the consequences for maternal
physiology and fetal growth are not fully understood. Objective To study whether changes in …

Background Maternal obesity has been implicated in the origins of childhood obesity
through a suboptimal environment in‐utero. Objective We examined relationships of …

Background Maternal overweight and obesity during pregnancy is associated with insulin
resistance, hyperglycaemia, hyperlipidaemia and a low-grade state of chronic inflammation …

Objective To identify metabolite patterns associated with childhood obesity, to examine
relations of these patterns with measures of adiposity and cardiometabolic risk, and to …

Context: The impact of specific maternal fuels and metabolic measures during early and late
gestation on neonatal body composition is not well defined. Objective: To determine how …

Background/Aims Obesity during pregnancy increases the risk of adverse clinical outcomes
and is associated with low-grade chronic inflammation. We describe maternal metabolic risk …